BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1646402)

  • 1. Reduced binding of TFIID to transcriptionally compromised mutants of VP16.
    Ingles CJ; Shales M; Cress WD; Triezenberg SJ; Greenblatt J
    Nature; 1991 Jun; 351(6327):588-90. PubMed ID: 1646402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.
    Stringer KF; Ingles CJ; Greenblatt J
    Nature; 1990 Jun; 345(6278):783-6. PubMed ID: 2193231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations that alter transcriptional activation but not DNA binding in the zinc finger of yeast activator HAPI.
    Kim KS; Guarente L
    Nature; 1989 Nov; 342(6246):200-3. PubMed ID: 2509943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between a transcriptional activator and transcription factor IIB in vivo.
    Colgan J; Wampler S; Manley JL
    Nature; 1993 Apr; 362(6420):549-53. PubMed ID: 8464496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of general transcription factor TFIIB to an acidic activating region.
    Lin YS; Ha I; Maldonado E; Reinberg D; Green MR
    Nature; 1991 Oct; 353(6344):569-71. PubMed ID: 1922364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with the assembly of a virus-host transcription complex by peptide competition.
    Haigh A; Greaves R; O'Hare P
    Nature; 1990 Mar; 344(6263):257-9. PubMed ID: 2156166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of human TFIID with the HIV-1 transactivator tat.
    Kashanchi F; Piras G; Radonovich MF; Duvall JF; Fattaey A; Chiang CM; Roeder RG; Brady JN
    Nature; 1994 Jan; 367(6460):295-9. PubMed ID: 8121496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of activation-defective TBP mutations on transcription initiation in yeast.
    Kim TK; Hashimoto S; Kelleher RJ; Flanagan PM; Kornberg RD; Horikoshi M; Roeder RG
    Nature; 1994 May; 369(6477):252-5. PubMed ID: 8183347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of transcriptional activation and repression can both involve TFIID.
    Manley JL; Um M; Li C; Ashali H
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Pearson A; Greenblatt J
    Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB.
    Gupta R; Emili A; Pan G; Xiao H; Shales M; Greenblatt J; Ingles CJ
    Nucleic Acids Res; 1996 Jun; 24(12):2324-30. PubMed ID: 8710503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain.
    Stern S; Herr W
    Genes Dev; 1991 Dec; 5(12B):2555-66. PubMed ID: 1684335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53.
    Xiao H; Pearson A; Coulombe B; Truant R; Zhang S; Regier JL; Triezenberg SJ; Reinberg D; Flores O; Ingles CJ
    Mol Cell Biol; 1994 Oct; 14(10):7013-24. PubMed ID: 7935417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of viral activators.
    Berk AJ; Boyer TG; Kapanidis AN; Ebright RH; Kobayashi NN; Horn PJ; Sullivan SM; Koop R; Surby MA; Triezenberg SJ
    Cold Spring Harb Symp Quant Biol; 1998; 63():243-52. PubMed ID: 10384288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical structural elements of the VP16 transcriptional activation domain.
    Cress WD; Triezenberg SJ
    Science; 1991 Jan; 251(4989):87-90. PubMed ID: 1846049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general mechanism for transcriptional synergy by eukaryotic activators.
    Chi T; Lieberman P; Ellwood K; Carey M
    Nature; 1995 Sep; 377(6546):254-7. PubMed ID: 7675113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain.
    Lai JS; Cleary MA; Herr W
    Genes Dev; 1992 Nov; 6(11):2058-65. PubMed ID: 1358756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression.
    Triezenberg SJ; Kingsbury RC; McKnight SL
    Genes Dev; 1988 Jun; 2(6):718-29. PubMed ID: 2843425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.